Target intelligence / Profile preview

RNA, U6 small nuclear 1003, pseudogene (RNU6-1003P)

Target
RNU6-1003P
Molecular classification
Pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, U6 small nuclear 1003, pseudogene (RNU6-1003P) is a non-coding RNA pseudogene annotated in the human genome[2]. It is classified as a pseudogene related to U6 small nuclear RNA (snRNA), which itself is essential in the spliceosome for pre-mRNA splicing[1][3]. However, as a pseudogene, RNU6-1003P does not produce a functional RNA or protein and is considered a nonfunctional genomic element without a defined molecular or biological role[2][4]. There is no evidence in the literature that this pseudogene is a receptor, enzyme, transporter, or any other traditional therapeutic target. No interacting drugs or disease associations have been described. Alternative names are simply the symbol RNU6-1003P. **Notes and clarifications:** - RNU6-1003P is not an active gene, RNA, or protein, but a genomic pseudogene, which means it is a relic of an ancestral gene with no known function[2][4]. - There is no indication that it is a therapeutic, diagnostic, or research target. - The term “U6 small nuclear RNA” refers to the active component of the spliceosome, but the “1003, pseudogene” variant is specifically a nonfunctional copy[2][4]. - This entry should be flagged as incorrect if used in a context requiring a druggable or actionable target. If structured information is being assembled for active molecular targets or genes, this entry is likely **not appropriate**.

Other names
RNU6-1003P
02

Biological functions

Other (no evidence for direct biological function)
03

Disease associations

Other (no known disease associations)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1003, pseudogene (RNU6-1003P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1003, pseudogene (RNU6-1003P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call